Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,972 public trials 2,027 recruiting studies

Immunoproliferative Disorders trial results

NCT06796517

Conditions
Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
Locations
  • Seoul St. Mary Hospital Seoul, South Korea
  • Yeoido St. Mary Hospital Seoul, South Korea
Conditions
Advanced Solid Tumor, HCC, Hemic and Lymphatic Diseases, +8 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Chaoyang, Beijing Municipality, China
  • Cangzhou Central Hospital Cangzhou, Hebei, China
  • Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +18 more
Locations
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • West China Hospital,Sichuan University Chengdu, Sichuan, China
Conditions
Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
  • AO Sant'Anna e San Sebastiano di Caserta Caserta, Italy
  • A.R.N.A.S. Garibaldi Catania, Italy
  • Azienda Ospedaliera Universitaria Arcispedale S. Anna Ferrara, Italy